doi: 10.1016/j.jneuroim.2008.12.002 146 MorganJTChanaGPardoCAAchimCSemendeferiKBuckwalterJet al
Potential therapeutic targets are low-grade systemic inflammation, oxidative stress, NO signaling, RAAS signaling, ECM remodeling, calcification, VSMCs, and cellular senescence
Qinglu Wang, [email protected] This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Another medication that receives attention is Tirzepatide, often recognized by the name Mounjaro in diabetes treatment discussions
Both forms share similar side effects, such as nausea and gastrointestinal discomfort